Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose cefditoren pivoxil in pediatric bacterial respiratory infections (Phase III)
jRCT2080221263Phase 3
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cefditoren in bacterial pneumonia, acute otitis media (AOM) and acute rhinosinusitis (ARS), sponsored by Meiji Seika Pharma Co., Ltd.
02
Drugs
cefditoren
03
Conditions
bacterial pneumoniaacute otitis media (AOM)acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on jRCT2080221263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221263.